Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
Original languageEnglish
Patent number8535674
Publication statusPublished - 1800

Fingerprint

Bone Neoplasms
Anti-Idiotypic Antibodies
Breast Neoplasms
Antibodies
interleukin 20

Cite this

@misc{9e8f51f094984c1194d7bbd9ba8737e6,
title = "Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody",
abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "8535674",

}

TY - PAT

T1 - Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

M3 - Patent

M1 - 8535674

ER -